About Vildagliptin API

CH₃ H₃C-O N
Therapeutic Category Anti Diabetic
CAS Number 274901-16-5
API Technology Novel API Development
Dose Form Tablets / Capsules
Synergene's Development Status Available
Available Regulatory Filing Under Validation / Process Optimization

Mechanism of Action

Vildagliptin is currently under laboratory validation and pilot process optimization for Anti Diabetic therapy.

Target Indication

Under development for Anti Diabetic indications. Scale-up batches in progress.